Iatrogenic hypercalcemia in a patient with type 2 diabetes and chronic kidney disease
A 59-year-old man with obesity, type 2 diabetes, CKD stage 3b, albuminuria and established cardiovascular disease receiving optimized treatment with renin–angiotensin–aldosterone system blockade, sodium-glucose cotransporter-2 inhibition, semaglutide and finerenone develops symptomatic severe non-parathyroid hormone-me...